Goodbody Health takes "next step" into blood testing market

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) group CEO George Thomas speaks to Proactive after launching a new platform that he describes as the "Uber for mobile phlebotomy."

Thomas reveals more about the market opportunity for the new service, adding that it represents the "next step" into the blood testing market for the UK-based aggregator of health and wellness products and services.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  264.14
-3.08 (-1.15%)
AAPL  300.23
+2.02 (0.68%)
AMD  424.10
-25.60 (-5.69%)
BAC  49.77
-0.08 (-0.16%)
GOOG  393.32
-3.85 (-0.97%)
META  614.23
-4.20 (-0.68%)
MSFT  421.92
+12.49 (3.05%)
NVDA  225.32
-10.42 (-4.42%)
ORCL  192.95
-2.66 (-1.36%)
TSLA  422.24
-21.06 (-4.75%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.